Essity AB stock (SE0009922164): Principal shareholder Industrivärden boosts stake amid strategic review

Investment firm Industrivärden, the principal shareholder in Essity, acquired 900,000 Class B shares in the hygiene and health products group on May 12, according to MarketScreener as of May 12, 2026. The transaction valued the shares at approximately SEK 223 million, representing a show of confidence from Essity's largest investor.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Essity AB: core business model

Essity is a global hygiene and health company headquartered in Sweden, operating across three main business segments: Consumer Tissue, Professional Hygiene, and Health and Medical Products. The company manufactures and distributes tissue products, incontinence care solutions, and medical devices to consumers and professional customers worldwide. Essity's portfolio includes well-known brands serving both retail and institutional markets, positioning it as a significant player in the global hygiene sector.

Strategic review and market context

The company initiated a strategic review of its Consumer Tissue business, according to PULPAPERnews as of May 13, 2026. This review reflects broader industry dynamics as the global toilet paper market is expected to reach $84.61 billion by 2031, driven by rising hygiene awareness and urbanization trends, according to market research cited by GlobeNewswire as of May 12, 2026. Essity competes alongside major players including Procter & Gamble, Kimberly-Clark, and Georgia-Pacific in this expanding market.

Stock performance on May 12 showed Essity shares gaining 1.68%, closing at 248.10 SEK on Nasdaq Stockholm, according to Investing.com as of May 12, 2026. The move reflects positive market sentiment despite broader index weakness.

Relevance for US investors

Essity's strategic positioning in the global hygiene market makes it relevant for US-based investors seeking exposure to essential consumer products and healthcare solutions. The company's international footprint and exposure to growing hygiene awareness trends align with long-term demographic and health-conscious consumer trends affecting North American markets. As a Nasdaq Stockholm-listed company with significant global operations, Essity offers diversified revenue streams beyond traditional tissue products.

Conclusion

Industrivärden's acquisition of 900,000 Essity shares on May 12 signals continued confidence from the company's principal shareholder at a time when Essity is conducting a strategic review of its Consumer Tissue operations. The move occurs within a favorable market backdrop for hygiene products, with global demand expected to expand significantly through 2031. Investors should monitor the outcomes of the strategic review and any announcements regarding the Consumer Tissue business direction.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.